The S&P 500 Is Doing Something It Hasn't Done in Decades. This ETF Could Be the Smarter Buy Right Now.

The S&P 500 has returned nearly 13% year to date, but its equal-weight counterpart has gained more than 14%, indicating broadening market participation beyond megacap technology. Technology represents roughly 37% of the cap-weighted Vanguard S&P 500 ETF, above the approximately 33% concentration at the tech-bubble peak, while the Invesco S&P 500 Equal Weight ETF holds about 15% in tech and charges a 0.20% expense ratio. The article argues that investors expecting continued rotation from AI-led megacaps toward smaller companies and other sectors could direct incremental allocations to the equal-weight ETF.

Analysis

The relevant signal is not headline concentration but whether earnings revisions begin diffusing beyond AI beneficiaries. RSP’s relative performance versus SPY is primarily a cyclical breadth and mean-reversion expression: it adds exposure to rate-sensitive financials, industrials, and smaller S&P constituents while systematically trimming prior winners at quarterly rebalances. That mechanism works best when index correlation falls and nominal growth remains intact; it is not a clean defensive allocation if growth or credit conditions deteriorate.

For GOOG, MSFT, and NVDA, a modest rotation need not impair fundamentals, but it can compress relative multiples as passive and benchmark-aware flows seek breadth. The near-term risk is mechanical: quarter-end rebalancing and institutional de-risking can create selling pressure in the largest winners even without estimate cuts. Over 6-18 months, however, an equal-weight regime requires a real improvement in ex-megacap margins and revenue revisions; absent that, the broadening trade becomes a positioning event rather than a durable leadership change.

Consensus is too quick to treat concentration as a timing signal. Concentrated indices can remain concentrated when earnings delivery supports it, and RSP’s quarterly rebalance embeds a structural short-momentum bias that becomes costly if AI capex continues translating into revenue concentration. The cleaner confirmation is sustained RSP/SPY outperformance alongside improving forward EPS revisions for financials, industrials, and consumer cyclicals—not simply a few weeks of relative-price strength.

Key Decisions for Investors

• Initiate a 1-3 month tactical pair: long RSP / short SPY in equal dollar notional only if RSP/SPY closes above its 50-day average and broad-sector EPS revisions turn positive. Target 3-5% relative return; exit if the ratio breaks the prior monthly low or if the 10-year Treasury yield rises sharply enough to pressure cyclicals.
• Maintain core exposure to MSFT and NVDA rather than broadly shorting megacap technology; hedge relative multiple risk with a modest RSP-over-QQQ pair into the next quarterly rebalance. Cover if AI leaders deliver upward revenue guidance revisions, since estimate momentum would likely overwhelm rotation flows.
• Use KRE and XLI as higher-beta breadth monitors rather than immediate longs. A durable advance in both versus SPY over 4-6 weeks would validate the RSP thesis; renewed regional-bank credit stress or weakening PMI data would invalidate it and favor returning to quality-growth exposure.
• Avoid treating IVZ as a direct proxy for RSP inflows. Any earnings benefit depends on persistent asset growth and fee realization, while broad ETF fee pressure can offset flow-driven AUM gains; wait for reported net flows and management fee-rate commentary before adding exposure.